These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27268129)

  • 1. Time to seroconversion of HBsAg to anti-HBs in individuals who lost HBsAg during follow-up.
    Roushan MR; Mohammadpour M; Baiany M; Soleimani S; Bijani A
    Epidemiol Infect; 2016 Sep; 144(12):2648-53. PubMed ID: 27268129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
    Xiang Y; Chen P; Xia JR; Zhang LP
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
    J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
    Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
    J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.
    Liu Y; Zhang L; Zhou JY; Pan J; Hu W; Zhou YH
    PLoS One; 2016; 11(1):e0146980. PubMed ID: 26751075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance.
    Seto WK; Tanaka Y; Wong DK; Shinkai N; Cheung KS; Liu KS; Fung J; Lai CL; Yuen MF
    Liver Int; 2016 May; 36(5):642-50. PubMed ID: 26474013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Bismuth E; Martinot-Peignoux M; Boyer N; Degott C; Erlinger S; Benhamou JP
    Hepatology; 1992 Jan; 15(1):32-6. PubMed ID: 1727796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.
    Ferreira SC; Chachá SG; Souza FF; Teixeira AC; Santana RC; Villanova MG; Zucoloto S; Ramalho LN; Perdoná GS; Passos AD; Martinelli AL
    Ann Hepatol; 2014; 13(6):762-70. PubMed ID: 25332262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
    Vyas AK; Sharma BC; Sarin SK; Trehanpati N
    Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection.
    Masrour-Roudsari J; Hasanjani-Roushan M; Yahyapour Y; Barari-Savadkoohi R; Bijani A; Sadeghi F; Mohammadnia-Afroozi M
    Caspian J Intern Med; 2020; 11(2):205-210. PubMed ID: 32509250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region.
    Liu W; Hu T; Wang X; Chen Y; Huang M; Yuan C; Guan M
    Arch Virol; 2012 Apr; 157(4):627-34. PubMed ID: 22222283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B.
    Kwak MS; Chung GE; Yang JI; Yim JY
    Sci Rep; 2019 Dec; 9(1):19417. PubMed ID: 31857656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBeAg seroconversion in children infected during early childhood with hepatitis B virus.
    Roushan MR; Bijani A; Ramzaninejad S; Roushan MH; Amiri MJ; Baiani M
    J Clin Virol; 2012 Sep; 55(1):30-3. PubMed ID: 22727680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease.
    Chen MH; Lee IC; Chen MH; Hou MC; Tsai CY; Huang YH
    Ann Rheum Dis; 2021 Nov; 80(11):1393-1399. PubMed ID: 34187776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological Determinants of Spontaneous Postpartum e Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus.
    Hu Y; Feng Z; Liu J; Chen J; Zhang S; Zhou YH
    Arch Med Res; 2016 Apr; 47(3):207-13. PubMed ID: 27387022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure.
    Liu Y; Ren S; Ma L; Lin X; Li H; Lu J; Cao Z; Zheng S; Hu Z; Chen X
    Braz J Infect Dis; 2023; 27(6):103703. PubMed ID: 38036020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.